v3.26.3
Supplemental equity and other information - Narrative (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
shares
$ / shares
Sep. 30, 2025
USD ($)
Dec. 31, 2025
$ / shares
shares
Stockholders Equity Note [Line Items]          
Share-based compensation expense | $ $ 2,630 $ 1,877 $ 7,202 $ 6,838  
Unrecognized compensation cost related to non-vested share-based compensation | $ $ 31,700   $ 31,700    
Weighted average period (in years)     2 years 6 months    
Preferred stock authorized (in shares) 300,000   300,000   300,000
Preferred stock, par value (in dollars per share) | $ / shares $ 0.01   $ 0.01   $ 0.01
Preferred stock, issued (in shares) 0   0   0
Stock Repurchase Program          
Stockholders Equity Note [Line Items]          
Shares authorized for repurchase, value | $ $ 100,000   $ 100,000    
Repurchase of common stock (in shares)     0    
Remaining authorized shares for share repurchase program | $ $ 96,900   $ 96,900    
Preferred Stock          
Stockholders Equity Note [Line Items]          
Issuance of preferred stock (in shares)     0    
Restricted Stock Units          
Stockholders Equity Note [Line Items]          
Granted (in shares) 3,468,000   3,588,000    
Restricted Stock Units | Tranche Two          
Stockholders Equity Note [Line Items]          
Vesting, percentage     33.30%    
Restricted Stock Units | Tranche One          
Stockholders Equity Note [Line Items]          
Vesting, percentage     33.30%    
Restricted Stock Units | Tranche Three          
Stockholders Equity Note [Line Items]          
Vesting, percentage     33.30%    
Performance Shares          
Stockholders Equity Note [Line Items]          
Granted (in shares) 249,000   249,000    
Cash Performance Units and Long-Term Cash Awards          
Stockholders Equity Note [Line Items]          
Vesting period (in years)     3 years    
Unrecognized compensation expense | $ $ 11,000   $ 11,000    
2031 Notes | Convertible Debt          
Stockholders Equity Note [Line Items]          
Aggregate shares receivable upon conversion (in shares)     143,900,000    
Securities excluded from computation of earnings per share, amount (in shares)     99,100,000    
2027 Notes | Convertible Debt          
Stockholders Equity Note [Line Items]          
Aggregate shares receivable upon conversion (in shares)     14,300,000    
Securities excluded from computation of earnings per share, amount (in shares)     9,400,000